Stock Information
ACADIA Pharmaceuticals Inc (ACAD)
Ticker Symbol: ACAD
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $4,798.03 mil
Piotroski score: 4
PE Ratio: 9.15
EPS (TTM): 2.21
Revenue (TTM): $6.59 M
Dividend Yield: N/A
ROE: 32.39%
Latest News
-
Acadia Pharmaceuticals Announces Allowance of U.S. Patent Covering Weight-Banded Dosing of Trofinetide, extending U.S. patent protections to March 2041
Mon, Sep 28, 2026 8:05 PM
-
3 Stocks Put Traders Are Targeting Today: AMTX, ACAD, REZI
Mon, Sep 28, 2026 3:30 PM
-
Acadia Pharmaceuticals (ACAD) Stock Trades At A Discount After A 29% Drop
Sun, Sep 27, 2026 7:09 AM
-
ACAD Stock Tumbles Today: Analysts Weigh RADIANT Results, Cut Price Targets
Fri, Sep 25, 2026 3:22 PM
-
ACAD Stock Down 13% as Phase II Alzheimer's Study Misses Primary Goal
Fri, Sep 25, 2026 3:02 PM
-
Acadia chugs on with Alzheimer’s psychosis programme despite Phase II miss
Fri, Sep 25, 2026 3:01 PM
-
Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s data
Fri, Sep 25, 2026 1:21 PM
-
Deutsche Bank Maintains Buy on ACADIA Pharmaceuticals, Lowers Price Target to $31
Fri, Sep 25, 2026 12:24 PM
-
HC Wainwright & Co. Maintains Buy on ACADIA Pharmaceuticals, Lowers Price Target to $33
Fri, Sep 25, 2026 10:43 AM
-
AMD To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday
Fri, Sep 25, 2026 8:56 AM
Key Financials
Financial data not available